Expression Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a curative autologous stem cell therapy for hemophilia A, today announced that the U.S. Food and Drug ...
Just like a doctor adjusts the dose of a medication to the patient's needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to ...
The ability to control the expression of therapeutic genes within a “therapeutic window” is crucial to ensure the development of safe and effective gene therapies, but to date, there has been no ...
CAMBRIDGE, MA -- Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene therapy treatments that could cure such diseases by ...
Researchers addressed the need for long-term expression of CCR5-specific antibodies to establish protection from HIV using ...
Contemporary AD systemic selection remains largely preference- and logistics-driven, despite modest EASI-75/EASI-90 response rates with Th2 biologics and JAK inhibitors at 12–16 weeks. The GEP-497 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results